-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BOLD-100 in Colorectal Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BOLD-100 in Colorectal Cancer Drug Details: BOLD-100 (IT-139, NKP-1339) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BOLD-100 in Colon Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BOLD-100 in Colon Cancer Drug Details: BOLD-100 (IT-139, NKP-1339) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BOLD-100 in Pancreatic Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BOLD-100 in Pancreatic Cancer Drug Details: BOLD-100 (IT-139, NKP-1339) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BOLD-100 in Gastric Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BOLD-100 in Gastric Cancer Drug Details: BOLD-100 (IT-139, NKP-1339) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BOLD-100 in Gastrointestinal Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BOLD-100 in Gastrointestinal Tumor Drug Details: BOLD-100 (IT-139, NKP-1339) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BOLD-100 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BOLD-100 in Solid Tumor Drug Details: BOLD-100 (IT-139, NKP-1339) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BOLD-100 in Metastatic Pancreatic Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BOLD-100 in Metastatic Pancreatic Cancer Drug Details: BOLD-100 (IT-139, NKP-1339) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BOLD-100 in Metastatic Colorectal Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BOLD-100 in Metastatic Colorectal Cancer Drug Details: BOLD-100 (IT-139, NKP-1339) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BOLD-100 in Bile Duct Cancer (Cholangiocarcinoma)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BOLD-100 in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: BOLD-100 (IT-139, NKP-1339) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BOLD-100 in Gastroesophageal (GE) Junction Carcinomas
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BOLD-100 in Gastroesophageal (GE) Junction Carcinomas Drug Details: BOLD-100 (IT-139, NKP-1339) is under development...
-
Product Insights
AEP – New Albany BOLD Transmission Line – Ohio
Equip yourself with the essential tools needed to make informed and profitable decisions with our AEP - New Albany BOLD Transmission Line - Ohio report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
SA Water Corp – Mount Bold Dam Safety Upgrade – South Australia
Equip yourself with the essential tools needed to make informed and profitable decisions with our SA Water Corp - Mount Bold Dam Safety Upgrade - South Australia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Trafford Council/ Trafford Hsg Trust – Bold Street Residential Community – Trafford
Equip yourself with the essential tools needed to make informed and profitable decisions with our Trafford Council/ Trafford Hsg Trust - Bold Street Residential Community - Trafford report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Trafford Council/ Trafford Hsg Trust – Bold Street Affordable Housing – Manchester
Equip yourself with the essential tools needed to make informed and profitable decisions with our Trafford Council/ Trafford Hsg Trust - Bold Street Affordable Housing - Manchester report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ecopipam Hydrochloride in Tourette Syndrome
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ecopipam Hydrochloride in Tourette Syndrome Drug Details:Ecopipam hydrochloride (PSYRX-101) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – HZA-018 in Marginal Zone B-cell Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.HZA-018 in Marginal Zone B-cell Lymphoma Drug Details:HZA-018 is under development for the treatment of B...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TP-3654 in Myelofibrosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TP-3654 in Myelofibrosis Drug Details:TP-3654 (SGI-9481) is under development for the treatment of bladder cancer, primary...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Inobrodib in Relapsed Acute Myeloid Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Inobrodib in Relapsed Acute Myeloid Leukemia Drug Details:Inobrodib (CCS-1477) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Brilaroxazine in Psychosis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brilaroxazine in Psychosis Drug Details: RP-5063 is under development for the treatment of schizophrenia,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Tivozanib hydrochloride in Bile Duct Cancer (Cholangiocarcinoma)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Tivozanib hydrochloride in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: Tivozanib Hydrochloride (Fotivda) is a quinoline...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.